1.	Study With Intensity Modulated Radiation Therapy With Cisplatin to Treat Stage I-IVA Cervical Cancer Phase: Phase III, Phase II Type: Treatment Status: Active Age: 18 and over Sponsor: NCI, Other Protocol IDs: INTERTECC, R21CA162718-01, NCT01554397
2.	Extraperitoneal Para-aortic Lymph Node Dissection (EPLND) for Cervix Phase: Phase III Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 2010-0952, NCT01365156
3.	Cisplatin and Radiation Therapy With or Without Carboplatin and Paclitaxel in Patients With Locally Advanced Cervical Cancer Phase: Phase III Type: Supportive care, Treatment Status: Active Age: 18 and over Sponsor: NCI, Other Protocol IDs: CDR0000706698, ANZGOG-0902-GOG-0274/RTOG-1174, ANZGOG-0902-GOG-0274, NCT01414608
4.	Oral Versus Transdermal Ondansetron for Women With Cervical Cancer Receiving Chemoradiation Phase: Phase III Type: Supportive care, Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 2011-1107, NCT01536392
5.	Standard Versus Intensity-Modulated Pelvic Radiation Therapy in Treating Patients With Endometrial or Cervical Cancer Phase: Phase III Type: Biomarker/Laboratory analysis, Supportive care, Treatment Status: Active Age: 18 and over Sponsor: NCI, Other Protocol IDs: CDR0000738944, RTOG-1203, NCT01672892
6.	Weekly IV Topotecan and Cisplatin With Radiation in Cervical Carcinoma Phase: Phase II Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: UCI 03-33, NCT00257816
7.	Cetuximab, Cisplatin, and Radiotherapy in Women With Locally Advanced Cervical Carcinoma Phase: Phase II Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: IRB-HSR#13748, CA225243, HRPO #05-0702, NCT00292955
8.	Study of Advanced Bulky Malignancies With Spatially Fractioned Radiation Therapy Phase: Phase II Type: Supportive care, Treatment Status: Active Age: 18 to 80 Sponsor: Other Protocol IDs: GRID, NCT00765570
9.	Copper Cu 64-ATSM and PET/CT Scan in Predicting Disease Progression in Patients With Newly-Diagnosed Stage IB, Stage II, Stage III, or Stage IVA Cervical Cancer Who Are Undergoing Chemoradiotherapy Per NCCN Guidelines Phase: Phase II Type: Diagnostic, Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: CDR0000624407, ACRIN-6682, NCT00794339
10.	Ixabepilone to Treat Cervical Cancer Phase: Phase II Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 18 to 80 Sponsor: NCI Protocol IDs: 090037, 09-C-0037, NCT00924066
11.	Vaccine Therapy in Treating Patients With Persistent or Recurrent Cervical Cancer Phase: Phase II Type: Treatment Status: Active Age: 18 and over Sponsor: NCI, Other Protocol IDs: GOG-0265, NCI-2011-02671, NCT01266460
12.	Image-Guided Gynecologic Brachytherapy Phase: Phase II Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 11-098, NCT01399658
13.	A Phase II Study of Lymphodepletion Followed by Autologous Tumor-Infiltrating Lymphocytes and High-Dose Adesleukin for Human Papillomavirus-Associated Cancers Phase: Phase II Type: Treatment Status: Active Age: 18 and over Sponsor: NCI Protocol IDs: 120116, 12-C-0116, NCT01585428
14.	Eribulin Mesylate in Treating Patients With Advanced or Recurrent Cervical Cancer Phase: Phase II Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 18 and over Sponsor: NCI, Other Protocol IDs: 5C-11-2, NCI-2012-01378, NCT01676818
15.	Cisplatin and Radiation Therapy With or Without Triapine in Treating Patients With Previously Untreated Stage IB-IVA Cervical Cancer or Stage II-IVA Vaginal Cancer Phase: Phase II Type: Biomarker/Laboratory analysis, Treatment Status: Approved-not yet active Age: 18 and over Sponsor: NCI Protocol IDs: NCI-2013-00804, CASE 4812, U01CA062502, NCT01835171
16.	Olaparib in Combination With Carboplatin for Refractory or Recurrent Women's Cancers Phase: Phase I Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 18 and over Sponsor: NCI Protocol IDs: 110022, 11-C-0022, NCT01237067
17.	Endoxifen in Adults With Hormone Receptor-Positive Solid Tumors Phase: Phase I Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 18 and over Sponsor: NCI Protocol IDs: 110061, 11-C-0061, NCT01273168
18.	Cisplatin and Radiation Therapy Followed by Paclitaxel and Carboplatin in Treating Patients With Stage I, Stage II, Stage III, or Stage IV Cervical Cancer Phase: Phase I Type: Treatment Status: Active Age: 18 and over Sponsor: NCI, Other Protocol IDs: CDR0000695304, GOG-9926, NCT01295502
19.	Doxorubicin With or Without Sildenafil, With Analysis of Cardiac Markers Phase: Phase I Type: Biomarker/Laboratory analysis, Supportive care, Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: MCC-13419, NCI-2011-0098, NCT01375699
20.	Safety Study of Nelfinavir + Cisplatin + Pelvic Radiation Therapy to Treat Cervical Cancer Phase: Phase I Type: Biomarker/Laboratory analysis, Diagnostic, Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: EPROST-20100153, NCT01485731
21.	Intensity Modulated Radiation Therapy With Cisplatin and Gemcitabine to Treat Locally Advanced Cervical Carcinoma Phase: Phase I Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: UCSD 100597, NCT01554410
22.	Carboplatin, Gemcitabine Hydrochloride, and Stereotactic Body Radiation Therapy in Gynecological Cancer Phase: Phase I Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 19 and over Sponsor: NCI, Other Protocol IDs: CASE8810, NCI-2012-00608, NCT01652794
23.	Chemoradiation Therapy and Ipilimumab in Treating Patients With Locally Advanced Cervical Cancer Phase: Phase I Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 18 and over Sponsor: NCI Protocol IDs: NCI-2012-01733, GOG-9929, U10CA027469, NCT01711515
24.	Chemoradiation-Induced Nausea and Emesis: Quality of Life Phase: No phase specified Type: Natural history/Epidemiology, Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 2003-0529, NCT00394602
25.	Image-guided Adaptive Radiotherapy for Cervix Cancer: Patient Image Acquisition Phase: No phase specified Type: Health services research, Treatment Status: Active Age: 18 and over Sponsor: NCI, Other Protocol IDs: HM10390, P01CA116602, NCT00571415